Travere Therapeutics to Participate at Upcoming Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:
Guggenheim’s 2nd Annual Healthcare Innovation Conference
Presenting on Tuesday, November 11, 2025, at 9:00 a.m. ET
Stifel 2025 Healthcare Conference
Wednesday, November 12, 2025
TD Cowen Immunology & Inflammation Summit
Presenting on Thursday, November 13, 2025, at 4:00 p.m. ET
Jefferies Global Healthcare Conference
Presenting on Tuesday, November 18, 2025, at 3:00 p.m. GMT (10:00 a.m. ET)
8th Annual Evercore Healthcare Conference
Presenting on Tuesday, December 2, 2025, at 10:50 a.m. ET
Piper Sandler 37th Annual Healthcare Conference
Wednesday, December 3, 2025
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251104923461/en/
Investors:
888-969-7879
[email protected]
Media:
888-969-7879
[email protected]
KEYWORDS: California United States North America
INDUSTRY KEYWORDS: Health Other Health Research Pharmaceutical Science Biotechnology
MEDIA:
| Logo |
 |